Health Tech Capitol | Invenra, Developer of Therapeutic Antibodies, Raises $2.9M
15957
post-template-default,single,single-post,postid-15957,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Invenra, Developer of Therapeutic Antibodies, Raises $2.9M

05 Oct Invenra, Developer of Therapeutic Antibodies, Raises $2.9M

Posted at 11:44h in Uncategorized by
0 Likes

Xconomy Wisconsin — Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceuticals companies and other clients, has raised more than $2.9 million from investors, according to a regulatory filing.

Twenty-five investors participated in the equity funding round, according to the filing, which was made public on Thursday. Invenra, founded in 2011, has now raised more than $14 million in equity and debt financing, according to SEC documents.

Some of the money raised in the latest funding round will go toward research and development efforts, and to compensate executives at the company, Invenra said in the filing.

Read more at Xconomy Wisconsin

No Comments

Sorry, the comment form is closed at this time.